We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.60 | 9.40 | 9.80 | 9.60 | 9.60 | 9.60 | 114,837 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.44 | 89.07M |
Date | Subject | Author | Discuss |
---|---|---|---|
15/2/2018 20:42 | New Hardman report:- | miavoce | |
15/2/2018 18:20 | Not that it really matters but when RG was asked about "which Moditope adjuvant" at the 2017-10 AGM and didn't say, the (possible) clue was in the 2017-09-13 CIMT poster abstracts pdf: B007 / Conjugation of peptide vaccine directly to TLR agonists generates enhanced immune responses and tumor therapy Brentville V, [snip] Durrant L, ... ISA Pharmaceuticals BV. "These studies suggest that intradermal injection of citrullinated peptide linked directly to a Th1 polarising adjuvant such as TLR1/2 or TLR9 agonist should be considered for translation into the clinic." Or am I just slow here having only just noticed? | djt59 | |
15/2/2018 16:33 | O N W - Great Minds .... Guffaw | the real lozan | |
15/2/2018 16:29 | J777J I honestly don't think it will have a massive effect straight away. The money is specifically for the " challenge ", none of it will flow directly to SCLP. | tosh 123 | |
15/2/2018 16:28 | J777J Personally I think that the CRUK award has more to do with Prestige/PR/Cred as it won't take any development costs away from the company but will underline the Platforms' cred in a Global environment. When you think about it it's more likely to become a negative for the share price if they DON'T get a substantial award... If they do , well it's what we all and the market now expects isn't it? AIMO ATB | oldnotwise | |
15/2/2018 16:18 | Any thoughts on the share price if they win the £20 million grant from CRUK? They are already collaborating so must have a fairly good chance of scooping the pot. | j777j | |
15/2/2018 16:16 | As I said the other day, in my experience, if the BOD suddenly become active and are out there shouting about their company, it normally follows that a raising isnt too far behind.... Lets wait and see. | tosh 123 | |
15/2/2018 16:14 | Lozan, normally I would agree with you 100%, and it does smack of a pump before a fund raise, especially with what we now know eg ;- £12 mill required within 6 months as well as the electricity money, but... I'm really hoping that our new CEO has taken note of our former CEO's numerous gaffs, and has decided to do things in an honourable manner. RG lost a lot of respect from many people ( myself included ), I think that the new BOD are more than aware of this, and will conduct themselves accordingly. But hey, who knows ? Its just nice to see reasonable volume and a blue number... its been way too long ! Not sure whether the share price can continue the upward momentum for long, but lets enjoy it while it lasts. | tosh 123 | |
15/2/2018 16:04 | Loz , very noticeable in the Interview that the dreaded funding was not mentioned. I guess Cliff wanted to avoid that subject. | panama7 | |
15/2/2018 15:55 | PP S- Anyone think this 'might' be being {a} 'set-up' for a 'fund-raising/ placing' ??? | the real lozan | |
15/2/2018 15:53 | P S - Re = LULL I will of course be happy to be proed WRONG.... for ONCE o / - | the real lozan | |
15/2/2018 13:32 | Well fwiw - a small cohort for Phase I of the trial would prove up toxicity (or lack of hopefully) & on the back of that they may have agreement in principle. | gooosed | |
15/2/2018 13:25 | Goosed, what’s your take on that? Purely down to funding or others input? | rhatton | |
15/2/2018 13:22 | Significant scale back in SCIB1 Phase I/II trial . . . . . | gooosed | |
15/2/2018 10:37 | Loz Well, I should have written,"I,like you can only hope...." Yes I know we were agreeing and the IP is the only thing we have ATM.... But a nice newly announced income stream / capital injection from a well negotiated licensing/collaborat As I see it we're on a bed of hope ATM, lets hope we're not disappointed near term, but sadly that's still a possibility. AIMO ATB | oldnotwise | |
15/2/2018 10:30 | O N W - "I can only hope that we don't sell the family silver for peanuts, " THAT was EXACTLY my point SCLP don't have 'much else' to 'bargain with'.... other than 'the IP' | the real lozan | |
15/2/2018 10:25 | I see the market is already reacting and 'taking-the-shine-of | the real lozan | |
15/2/2018 10:24 | Loz, Agree the funding's the key now. Sadly people don't seem to understand that the science became secondary to the commercialisation some years ago, and although the science continued to glitter, the financing didn't. Now I'm with you, we're at a junction where the BOD's negotiations/accepta The manner in which the funding is achieved is also seriuosly important, and wouldn't it be interesting if we had to endure another two or three years of inaction if the purse strings were held tightly shut against any terms the BOD insisted on enforcing rather than "give away" the IP too cheaply? I doubt that but it's not impossible. We have one trial funded already and that's a start. What comes next is an unknown, but surely the BOD wouldn't have entered into a collaboration requiring capital if that hadn't been secured already at an attractive term? I hope not. So again (always the same now) maybe wait and see. I can only hope that we don't sell the family silver for peanuts, but that's something that can't be controlled from our side! In the BOD we trust? AIMO ATB | oldnotwise | |
15/2/2018 10:17 | P7 - post re Timescales ...Quite right No one seems to have *clocked-it* Nor has the mention today in RNS of 2019.... sunk-in | the real lozan | |
15/2/2018 10:03 | Tosh I'll leave you to a more in depth discussion with someone who knows about NIPT ;-) ATB | oldnotwise |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions